{
    "code": "52027282",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027282",
    "time": "2020-02-21 03:32:07",
    "許可證字號": "衛部藥輸字第027282號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/10\/03",
    "發證日期": "106\/10\/03",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202728204",
    "中文品名": "朗斯弗膜衣錠20毫克",
    "英文品名": "LONSURF Film-Coated Tablets 20 mg",
    "適應症": "1. 轉移性大腸直腸癌\r\n適用於治療先前曾接受下列療法的轉移性大腸直腸癌之成人病人，包括fluoropyrimidine、oxaliplatin及 irinotecan為基礎的化療，和抗血管內皮生長因子(anti-VEGF)療法；若RAS為原生型(wild type)，則需接受過抗表皮生長因子受體(anti-EGFR)療法。\r\n2. 轉移性胃癌\r\n適用於治療先前曾接受 兩種(含)以上治療（包括含fluoropyrimidine—、platinum—、taxane—或 irinotecan為基礎的化學療法，以及HER2\/neu標靶治療[如果適合]）的轉移性胃腺癌或胃食道接合處腺癌病人。",
    "劑型": "116膜衣錠",
    "包裝": "8-1000粒PTP 鋁箔盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "新成分",
    "主製造廠": {
        "限制項目": "02輸　入 5F免除銜接性試驗",
        "申請商名稱": "6201125122  台灣東洋藥品工業股份有限公司",
        "申請商地址": "台北市南港區園區街3之1號3樓",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5204600200",
            "成分名稱": "Trifluridine",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "5204600300",
            "成分名稱": "Tipiracil hydrochloride",
            "含量描述": "(EQ 8.19 mg base)",
            "含量": "9.4200000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "020272820004 藥物外觀(背面)-107-01-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027282&Seq=002&Type=10"
        },
        {
            "title": "020272820004 藥物外觀(正面)-107-01-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027282&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "02. LONSURF package insert revised on 20191223_15mg&20mg_完稿版-108-12-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027282&Seq=002&Type=9"
        },
        {
            "title": "020272820003 鋁袋 (20顆裝)-107-01-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027282&Seq=004&Type=8"
        },
        {
            "title": "020272820003 外盒 (20顆裝)-107-01-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027282&Seq=003&Type=8"
        },
        {
            "title": "020272820002 鋁箔背面 (10顆裝)-107-01-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027282&Seq=002&Type=8"
        },
        {
            "title": "020272820002 鋁箔正面 (10顆裝)-107-01-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027282&Seq=001&Type=8"
        }
    ]
}